BOULDER, Colo., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines, today announced that Nichoals Saccomano, Ph.D., President and Chief Executive Officer, will present and be available for one-on-one investor meetings at the following investor conferences: A fireside chat at the Guggenheim Healthcare Innovation Conference, in Boston on Monday, November 10, 2025, at 4:00 p.m. ET. A live ...

Initial Rollout to Include 188 Locations with Additional Expansions PlannedATLANTA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced its partnership with GPM Investments, LLC, a wholly owned subsidiary of ARKO Corp. (NASDAQ: ARKO) and one of the nation’s largest convenience-store owners and operators. The agreement will bring Bitcoin Depot BTMs to 188 initial locations.Through this partnership, Bitcoin Depot ...

Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member baseHigh coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-market growth, and profitable returning member cohorts position Clover for improved positive FY26 Financial Results Fin ...

Meets or exceeds all third quarter guidance metrics GAAP Net income of $5.2 million reflects $35 million year-over-year improvement GAAP EPS of $0.11, up $0.86 versus prior-year period Adjusted EPS of $0.39, up sharply versus $0.02 in 3Q24 Operating expenses reduced 11% year-over-year, supporting continued margin expansion SAN CARLOS, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Oportun Financial Corporation (Nasdaq: OPRT) (“Oportun”, or the "Company") today reported financial results for the third quarter e ...

合作核心内容 - Arteris公司宣布Altera已获得其广泛产品组合的授权，用于开发下一代FPGA和SoC FPGA解决方案 [1] - 此次合作旨在利用Arteris的IP和软件产品来简化设计工作流程、优化数据移动，并赋能数据中心、通信、视觉、工业自动化、机器人、航空航天和国防应用中的智能计算 [1] 技术细节与应用 - Altera将部署Arteris的Ncore缓存一致性互连IP、FlexGen智能片上网络IP、用于设计集成自动化的Magillem Connectivity以及用于硬件软件集成的Magillem Registers [2] - 该技术组合将帮助Altera高效简化组装、优化片上数据移动，并加速下一代可编程架构的开发，以满足各种终端市场的动态需求 [2] - Ncore缓存一致性NoC IP、FlexGen智能NoC IP和Magillem软件的结合为开发先进半导体提供了强大基础，可优化数据移动效率、实现系统级自动化并满足一致性数据处理需求，从而提升性能并缩短上市时间 [3] 合作方评价与意义 - Altera方面表示，Arteris技术对于更快地将创新可编程解决方案推向市场至关重要，其经过硅验证的IP和软件使设计和集成更简单、更快速、风险更低 [3] - Arteris方面认为，Altera的信任证明了高性能互连IP和设计自动化软件对于推动先进设计、实现快速创新的重要性日益增长 [3] 公司背景 - Arteris是系统IP领域的全球领导者，其片上网络互连IP和片上系统集成自动化软件被全球顶级半导体和科技公司用于提升整体性能、工程生产率、降低风险与成本，并更快地将复杂设计推向市场 [4]

Over 3 million Paid Subscribers, up 6% over Q3 2024 Q3 2025 revenue of $170.4 million, up 2% compared to Q3 2024 Net income of $20.5 million, up 79% compared to Q3 2024 Recurring semi-annual dividend of $0.10 per share to be paid in January 2026 SOUTH JORDAN, Utah, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced financial results for its third quarter en ...

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “CGBD” or the “Company”) (NASDAQ: CGBD) today announced its financial results for its third quarter ended September 30, 2025. Justin Plouffe, CGBD’s Chief Executive Officer, said, “We continue to be active in the current market with disciplined underwriting standards. We experienced another quarter of net growth in the portfolio as we maintain leverage at the mid-point o ...

Third quarter total revenue of $160 million, Crysvita® revenue of $112 million and Dojolvi® revenue of $24 million Reaffirm 2025 Revenue Guidance: Total revenue between $640 million to $670 million, Crysvita revenue of $460 million to $480 million, and Dojolvi revenue of $90 million to $100 million Bolstered balance sheet with $400 million proceeds from sale of portion of Crysvita royalty interest NOVATO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceu ...

MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced plans to present at the upcoming Stifel 2025 Healthcare Conference and the Piper Sandler 37th Annual Healthcare Conference, both in New York, NY. Sight Sciences’ management is scheduled to present at the S ...

SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the quarter ended September 30, 2025. Third Quarter 2025 & Recent Highlights Reported total revenue of $22.6 million in the third quarter of 2025, a 31% increase compared to the same period in 2024Achieved gross margin of 88% compared to 87% for ...